Dr. Alvarenga Thiebaud is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
5323 Harry Hines Boulevard
Dallas, TX 75390Phone+1 214-645-4673Fax+1 214-645-2615- Is this information wrong?
Education & Training
City of Hope National Medical CenterFellowship, Hematopoietic Cell Transplantation, 2021
Temple University HospitalFellowship, Hematology and Medical Oncology, 2020
Bridgeport Hospital/Yale UniversityResidency, Internal Medicine, 2017
Universidad Nacional Autonoma de Honduras Class of 2002
Certifications & Licensure
TX State Medical License 2021 - 2025
CA State Medical License 2020 - 2024
PA State Medical License 2018 - 2022
DC State Medical License 2017 - 2018- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 7 citationsOER-073: A multicenter phase 2 study evaluating the role of pazopanib in angiosarcoma.Julio Alvarenga Thiebaud, Vinod Ravi, Samuel Litwin, Scott M Schuetze, Sujana Movva, Mark Agulnik, Andrew S Kraft, Eric D Tetzlaff, Neeta Somaiah, Margaret von Mehren> ;Cancer. 2022 Oct 1
Hospital Affiliations
University of Texas Southwestern Medical CenterDallas, Texas
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
